The IBiS receives subsidies from the following public funds aimed at achieving objectives linked to the general interest.
The Institute of Biomedicine of Seville (IBiS) is a multidisciplinary center whose objective is to carry out fundamental research on the causes and mechanisms of the most prevalent pathologies in the population and the development of new methods of diagnosis and treatment for them.
The IBiS is made up of 42 consolidated groups and 42 assigned groups led by researchers from the University of Seville, The Spanish National Research Council (CSIC) and the Virgen del Rocío, Virgen Macarena and Virgen de Valme University Hospitals organized around five thematic areas. : Infectious and Immune System Diseases, Neurosciences, Onco-hematology and Genetics, Cardiovascular Pathology, Respiratory / Other Systemic Pathologies and Liver, Digestive and Inflammatory Diseases.
The IBiS depends institutionally on the Ministry of Health and Consumer Affairs of the Junta de Andalucía; the Andalusian Health Service (SAS); the Department of University, Research and Innovation; the University of Seville and the Higher Council for Scientific Research (CSIC), and is managed by the Public Foundation for the Management of Health Research of Seville (FISEVI) according to BOE Agreement 306 of December 22, 2022.
For this reason, the IBiS receives public financing through the different entities that make it up.
